TGArchive
·1 хв читання · 37 слів·👁 8.6K17

Singapore biotech Mirxes files for Hong Kong IPO after raising US$50 million

Until recently, Singapore-based Mirxes was caught between listing locally or overseas. The Series D funding values the company at around US$600 million post-money, BT understands.

https://bt.sg/5ybK

Відкрити в Telegram
Повернутись до каналу